Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events
The Journal of Allergy and Clinical Immunology: In Practice · 2026-02 · 14 (2) · 482-494.e13
DOI: 10.1016/j.jaip.2025.10.032 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-02. Verfasst von Eugenio De Corso und 25 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy. Electronic address: eugenio.decorso@policlinicogemelli.it. Hauptthemen laut MEDLINE: Nasal Polyps, Sinusitis, Antibodies, Monoclonal, Humanized, Rhinitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Sanofi.
Themen: Patientensicherheit
Abstract (Originalsprache)
BACKGROUND: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with dupilumab may experience an increase in blood absolute eosinophil count (AEC). However, the onset and temporal pattern of dupilumab-induced blood eosinophilia (DIBE) have not been thoroughly investigated in real life. OBJECTIVE: To evaluate DIBE prevalence and temporal pattern in patients with CRSwNP, and to determine associations between DIBE and adverse events (AEs), patients' clinical characteristics, and treatment outcomes. METHODS: This is a multicentric historical prospective observational study conducted across 14 Italian centers of the DUPIREAL network. DIBE onset and temporal pattern, clinical characteristics, CRSwNP outcomes, and AEs were analyzed. DIBE was defined as an AEC increased by 50% from baseline and at least >500 cells/mm3, or AEC >1500 cells/mm3. RESULTS: A total of 564 patients with CRSwNP were enrolled. Mean AEC peaked at 3 months and declined by 12 months. Among patients developing DIBE (48.2%), 3 distinct temporal patterns were identified based on onset and duration: early-onset temporary (group 1, 30.7% patients), early-onset persistent (group 2, 14.4% patients), and late-onset (group 3, 3.2% patients). Asthma prevalence (P 1500 cells/mm3 was associated with a higher risk of developing mild AEs (P < 0.001). DIBE occurrence did not influence dupilumab outcomes in patients with CRSwNP. CONCLUSIONS: Distinct DIBE patterns have been identified in patients with CRSwNP based on eosinophilia temporal trends. DIBE was mainly observed in patients with comorbid asthma and previous use of systemic steroids. The findings confirm that DIBE is a mostly transient and harmless phenomenon associated only with mild AEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy. Electronic address: eugenio.decorso@policlinicogemelli.it.
- Department of Head, Neck and Sensory Organs, Catholic University of The Sacred Heart, Rome, Italy.
- Otorhinolaryngology Unit, Ospedale Bellaria Dip Chirurgie Specialistiche AUSL, Bologna, Italy.
- Department of Medical-Surgical Sciences and Advanced Technologies"G.F. Ingrassia", Director of E.N.T. Unit, P.O. "G. Rodolico", University of Catania, Catania, Italy.
- ENT Department, Azienda USL Reggio Emilia-IRCCS, Reggio Emilia, Italy.
- Otorhinolaryngology Unit, ASST Santi Paolo e Carlo Hospital, Milan, Italy; Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Förderung
- Sanofi
Zitieren
APA
De Corso, E., Montuori, C., Pasquini, E., La Mantia, I., Ghidini, A., Pipolo, C., Garzaro, M., Ottaviano, G., Seccia, V., Ciofalo, A., Torretta, S., Cantone, E., Danè, G., Pagella, F., Lucidi, D., Fadda, G. L., Mannocci, A., Cavaliere, C., Pagliuca, G., …, & Dupilumab Italian Study Group (2026). Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events. The Journal of Allergy and Clinical Immunology: In Practice, 14(2), 482-494.e13. https://doi.org/10.1016/j.jaip.2025.10.032
Vancouver
De Corso E, Montuori C, Pasquini E, La Mantia I, Ghidini A, Pipolo C, et al. Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(2):482-494.e13. doi:10.1016/j.jaip.2025.10.032
BibTeX
@article{DeCorso2026,
author = {De Corso, Eugenio and Montuori, Claudio and Pasquini, Ernesto and La Mantia, Ignazio and Ghidini, Angelo and Pipolo, Carlotta and Garzaro, Massimiliano and Ottaviano, Giancarlo and Seccia, Veronica and Ciofalo, Andrea and Torretta, Sara and Cantone, Elena and Danè, Giulia and Pagella, Fabio and Lucidi, Daniela and Fadda, Gian Luca and Mannocci, Alice and Cavaliere, Carlo and Pagliuca, Giulio and Canevari, Frank Rikki Mauritz and Settimi, Stefano and Bussu, Francesco and Corbo, Marco and Baroni, Silvia and Galli, Jacopo and Dupilumab Italian Study Group, Dupilumab Italian Study Group},
title = {Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {2},
pages = {482--494.e13},
doi = {10.1016/j.jaip.2025.10.032}
}
EUVIMED